Immunic (IMUX) Non-Current Assets (2013 - 2026)

Immunic has disclosed Non-Current Assets across 14 years of filings, most recently posting $983000.0 for Q1 2026.

• Non-Current Assets for Q1 2026 came in at $983000.0, down 36.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.2 million (down 14.81% YoY), and the FY2025 annual result was $1.2 million, down 22.98% from the prior year.
• Non-Current Assets came in at $983000.0 for Q1 2026 at Immunic, down from $1.2 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $34.4 million in Q3 2022 to a low of $983000.0 in Q1 2026.
• The 5-year median for Non-Current Assets is $1.6 million (2025), against an average of $7.4 million.
• Across the five-year window, Non-Current Assets sank 94.94% in 2023 and grew 4.89% in 2025, its largest moves.
• Immunic's Non-Current Assets stood at $1.9 million in 2022, then declined by 6.56% to $1.8 million in 2023, then decreased by 12.97% to $1.5 million in 2024, then declined by 22.98% to $1.2 million in 2025, then declined by 16.91% to $983000.0 in 2026.
• The last three Non-Current Assets figures came in at $983000.0 (Q1 2026), $1.2 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.